Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 2 4Phase EARLY_PHASE1 2Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 66Pancreatic Neoplasms 64Glioma 62Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 45Melanoma 44Head and Neck Neoplasms 43Recurrence 42Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 39Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 29Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Sarcoma 22Lymphoma, B-Cell 22Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Fasting × Clear all
NCT04617704 2021-09-22

BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
Plasma cell

Fasting, Multiple Myeloma

NCT04236011 2021-06-15

BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Unknown
15 enrolled
Plasma cell

Fasting, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡